Micro-X Limited (MX1.AX)
AUD 0.05
(-10.53%)
AUD 0.05
(-10.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 65 Thousand AUD | 0.0% |
| 2023 | 65 Thousand AUD | 0.0% |
| 2022 | 65 Thousand AUD | 0.0% |
| 2021 | 65 Thousand AUD | -98.86% |
| 2020 | 5.69 Million AUD | 89.7% |
| 2019 | 3 Million AUD | -40.0% |
| 2018 | 5 Million AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 65 Thousand AUD | 0.0% |
| 2024 Q4 | 65 Thousand AUD | 0.0% |
| 2024 FY | 65 Thousand AUD | 0.0% |
| 2023 FY | 65 Thousand AUD | 0.0% |
| 2023 Q4 | 65 Thousand AUD | 0.0% |
| 2023 Q2 | 65 Thousand AUD | 0.0% |
| 2022 Q4 | 65 Thousand AUD | 0.0% |
| 2022 FY | 65 Thousand AUD | 0.0% |
| 2022 Q2 | 65 Thousand AUD | 0.0% |
| 2021 FY | 65 Thousand AUD | -98.86% |
| 2021 Q4 | 65 Thousand AUD | 0.0% |
| 2021 Q2 | 5.52 Million AUD | 0.0% |
| 2020 Q2 | 4.54 Million AUD | 0.0% |
| 2020 FY | 5.69 Million AUD | 89.7% |
| 2020 Q4 | 5.69 Million AUD | 0.0% |
| 2019 Q2 | 6.75 Million AUD | 0.0% |
| 2019 Q4 | 3 Million AUD | 0.0% |
| 2019 FY | 3 Million AUD | -40.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | 5 Million AUD | 0.0% |
| 2018 Q4 | 5 Million AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 98.443% |
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 98.898% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | 95.749% |
| Control Bionics Limited | 336.16 Thousand AUD | 80.664% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 99.968% |
| CleanSpace Holdings Limited | 2.76 Million AUD | 97.65% |
| Cyclopharm Limited | 4.01 Million AUD | 98.38% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | 96.32% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 99.477% |
| ImpediMed Limited | 810 Thousand AUD | 91.975% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.74 Million AUD | 96.271% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | 91.24% |
| Respiri Limited | - AUD | -Infinity% |
| SomnoMed Limited | 709.07 Thousand AUD | 90.833% |
| Universal Biosensors, Inc. | 3.22 Million AUD | 97.985% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |